Biohaven (BHVN) Cash from Investing Activities (2021 - 2026)

Biohaven has reported Cash from Investing Activities for 6 years, with the latest figure at $15.2 million in Q1 2026.

• Quarterly Cash from Investing Activities fell 90.77% year-over-year to $15.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $150.9 million (up 232.22% YoY) and the FY2025 annual result came in at $300.6 million, up 222.69% from the prior year.
• Cash from Investing Activities rose to $15.2 million in Q1 2026 per BHVN's latest filing, from -$13.7 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $165.0 million in Q3 2025 and troughed at -$264.0 million in Q4 2022.
• A 5-year average of -$6.1 million and a median of -$3.9 million in 2023 frame the typical range for Cash from Investing Activities.
• The sharpest annual moves came in 2022 and 2024: Cash from Investing Activities tumbled 131251.24% in 2022, then soared 3313.5% in 2024.
• Over 5 years, Cash from Investing Activities stood at -$264.0 million in 2022, then jumped by 98.52% to -$3.9 million in 2023, then plunged by 2140.06% to -$87.7 million in 2024, then surged by 84.33% to -$13.7 million in 2025, then jumped by 210.72% to $15.2 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered $15.2 million, -$13.7 million, and $165.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.